RedHill Biopharma Investor Relations Material
Latest events
Q1 2022
RedHill Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from RedHill Biopharma Ltd
Access all reports
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company focused on the development and commercialization of treatments for gastrointestinal and infectious diseases. The company markets a portfolio of approved products in the United States and is also engaged in clinical development programs targeting conditions such as Crohn’s disease, Helicobacter pylori infection, and COVID-19. RedHill conducts research and commercial activities both independently and through strategic partnerships. The company is headquartered in Tel Aviv, Israel, and its shares are listed on the NASDAQ.
Key slides for RedHill Biopharma Ltd
Corporate Presentation
RedHill Biopharma Ltd
Corporate Presentation
RedHill Biopharma Ltd
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
RDHL
Country
🇺🇸 United States